Evolving functions of Dickkopf-1 in cancer and immunity

Nikolai Jaschke1, Lorenz C Hofbauer2, Andy Göbel2

  • 1Division of Endocrinology and Metabolic Bone Diseases, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Center for Healthy Ageing, Department of Medicine III, Technische Universität Dresden, Dresden, Germany; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Austria.

Cancer Letters
|April 7, 2020
PubMed

Insights

Dickkopf-1 (DKK-1), a Wnt-signaling inhibitor, is crucial in bone formation and cancer. Emerging research reveals its roles in angiogenesis and immunity, leading to clinical trials for anti-DKK-1 therapies in malignancies.

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Dickkopf-1 (DKK-1) is a key inhibitor of Wnt signaling, vital for bone formation.
  • Initially thought to be synthesized only in bone, DKK-1 is now known to be expressed in T-cells, platelets, and cancer cells.

Purpose of the Study:

  • To review the evolving understanding of DKK-1 functions beyond bone regulation.
  • To highlight the clinical implications of DKK-1 research, particularly in oncology.
  • To identify future research directions for DKK-1 in health and disease.

Main Methods:

  • Literature review of DKK-1 research.
  • Analysis of DKK-1's roles in angiogenesis, cancer biology, immune homeostasis, and inflammation.
  • Examination of ongoing clinical trials involving anti-DKK-1 antibodies.

Main Results:

  • DKK-1 plays significant roles in angiogenesis, cancer cell proliferation, and immune regulation.
  • Clinical trials are investigating anti-DKK-1 antibodies for various cancers.
  • DKK-1's pleiotropic functions are increasingly recognized.

Conclusions:

  • DKK-1 is a multifaceted molecule with implications beyond bone metabolism, especially in cancer.
  • Targeting DKK-1 presents a promising therapeutic strategy for malignancies.
  • Further research is needed to fully elucidate DKK-1's complex roles and optimize therapeutic applications.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.2K